82. Jahrestagung der Deutschen Gesellschaft für Kardiologie

Freitag, 1. April 2016 (Posterbereich 34) 16:00-17:30

Postervorträge

Klinisches Outcome nach koronarer Intervention

Diskussionsleiter: B. Levenson (Berlin)

(P1430) Long term clinical results of bioresorbable drug-eluting scaffolds in patients with and without diabetes
    S. Markovic, J. Seeger, B. Gonska, C. Rodewald, W. Rottbauer, J. Wöhrle (Ulm)
(P1431) Drug Eluting Balloon: The Impact of Lesion preparation of In Stent Restenosis with conventional balloon angioplasty on Clinical Outcome
    M. Almalla, J. Schröder, N. Marx, F. Vogt (Aachen)
(P1432) Treatment of In-Stent Restenosis with two Different Drug Eluting Balloons; Real Word Study
    M. Almalla, S. Reith, F. Vogt, M.-M. Becker, N. Marx, J. Schröder (Aachen)
(P1433) Bioresorbable Vascular Scaffolds Versus Everolimus Eluting Stents in patients with Acute Coronary Syndrome: a propensity score matched analysis from a multicenter “real-world” prospective registry
    A. H. Frangieh, Y. Imori, F. D'Ascenzo, T. Gori, T. Münzel, F. Ugo, G. Campo, E. Cerrato, L. C. Napp, M. Iannaccone, J.-R. Ghadri, E. Kazemian, R. K. Binder, M. Jaguszewski, A. Csordas, P. Capasso, S. Biscaglia, F. Conrotto, F. Varbella, R. Garbo, F. Gaita, P. Erne, T. F. Lüscher, C. Moretti, C. Templin (Zürich, Luzern, CH; Mainz, Hannover; Turin, Cona (FE), Rivoli TO, IT)
(P1434) 24-month clinical results after recanalization of true coronary chronic total occlusions with the Sirolimus eluting Orsiro stent
    S. Markovic, W. Rottbauer, J. Wöhrle (Ulm)
(P1435) Implantation of bioresorbable scaffolds in patients with indication for oral anticoagulation: is it safe?
    N. F. Boeder, V. Johnson, O. Dörr, J. Wiebe, A. Elsässer, H. Möllmann, C. W. Hamm, H. Nef, T. Bauer (Gießen, München, Oldenburg, Bad Nauheim)